Communiqués HLS Therapeutics Inc. OTC Markets

Actions

HLTRF

CA40390B1094

Produits pharmaceutiques

Marché Fermé - OTC Markets 19:15:38 01/10/2026			Varia. 5j.	Varia. 1 janv.
2,750 ^USD	-1,43 %		-1,43 %	-19,83 %

01/10	HLS Therapeutics Inc. annonce des changements au sein de son conseil d’administration et de ses comités	CI
24/09	HLS Therapeutics obtient l’autorisation de la Bourse de Toronto (TSX) d’augmenter son offre de rachat d’actions dans le cours normal des activités	MT

Communiqués

02/10	HLS Therapeutics : Investor Presentation Fall 2026	PU
01/10	HLS Therapeutics Announces Board of Directors Changes	AQ
24/09	HLS Therapeutics Increases Normal Course Issuer Bid	AQ
12/08	HLS Therapeutics : Q2 2026 Conference Call Presentation	PU
12/08	HLS Therapeutics Announces Q2 2026 Financial Results	AQ
05/08	HLS Therapeutics Provides Update on NILEMDO™ Market Access	AQ
29/07	HLS Therapeutics to Host Q2 2026 Financial Results Conference Call	AQ
26/06	HLS Therapeutics Reports Annual Meeting Results	AQ
23/06	HLS Therapeutics Announces Normal Course Issuer Bid	AQ
15/05	HLS Therapeutics : First Quarter 2026 Presentation	PU
15/05	HLS Therapeutics Announces Q1 2026 Financial Results	AQ
01/05	HLS Therapeutics to Host Q1 2026 Financial Results Conference Call	AQ
23/04	HLS Therapeutics : Investor Presentation	PU
14/04	HLS Therapeutics to Present at the 2026 Bloom Burton & Co. Healthcare Investor Conference	AQ
12/03	HLS Therapeutics : 2026 Annual Report 2026 Annual Information Form	PU
12/03	HLS Therapeutics Announces Fiscal 2025 Financial Results	AQ
26/02	HLS Therapeutics to Host Fiscal 2025 Financial Results Conference Call	AQ
13/11	HLS Therapeutics : Q3 2025 Conference Call Presentation	PU
13/11	HLS Therapeutics : Third Quarter 2025 MD&A	PU
13/11	HLS Therapeutics Announces Q3 2025 Financial Results	AQ
30/10/25	HLS Therapeutics to Host Q3 2025 Financial Results Conference Call	AQ
14/10/25	HLS Therapeutics and Amarin Collaborate on Presenting REDUCE-IT® and EPA Mechanistic Data at the Canadian Cardiovascular Congress	AQ
20/08/25	HLS Therapeutics Announces New Credit Agreement	AQ
14/08/25	HLS Therapeutics : Q2 2025 Conference Call Presentation	PU
31/07/25	HLS Therapeutics to Host Q2 2025 Financial Results Conference Call	AQ